Fortis Healthstaff Profile
Key Indicators
- Authorised Capital ₹ 5.10 Cr
as on 17-11-2024
- Paid Up Capital ₹ 5.10 Cr
as on 17-11-2024
- Company Age 40 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 356.72%
(FY 2023)
- Profit 43.91%
(FY 2023)
- Ebitda 97.87%
(FY 2023)
- Net Worth -6.76%
(FY 2023)
- Total Assets -17.20%
(FY 2023)
About Fortis Healthstaff
The Corporate was formerly known as Ranbexy Pharmaceuticals Private Linited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.10 Cr and a paid-up capital of Rs 5.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajey Maharaj, Ranjan Pandey, and Manu Kapila serve as directors at the Company.
- CIN/LLPIN
U85194DL1984PLC205390
- Company No.
205390
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Jan 1984
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fortis Healthstaff?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajey Maharaj  | Director | 24-May-2018 | Current |
| Ranjan Pandey | Director | 13-Dec-2019 | Current |
| Manu Kapila | Director | 24-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Fortis Healthstaff.
Fortis Healthstaff Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 356.72% increase. The company also saw a substantial improvement in profitability, with a 43.91% increase in profit. The company's net worth dipped by a decrease of 6.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortis Healthstaff?
In 2023, Fortis Healthstaff had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fortis Health Management (East) LimitedActive 13 years 8 monthsAjey Maharaj and Ranjan Pandey are mutual person
Fortis Csr FoundationActive 10 years 2 monthsAjey Maharaj, Ranjan Pandey and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fortis Healthstaff?
Fortis Healthstaff has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortis Healthstaff, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortis Healthstaff's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
